跳至主要内容
临床试验/CTRI/2023/09/058150
CTRI/2023/09/058150尚未招募Phase 3 4

Evaluation of effectiveness and safety of Nanofat transfer in Androgenetic Alopecia - An interventional study

Varsha M1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2023年10月20日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
15
试验地点
1
主要终点
Trichoscopic improvement in hair density and hair diameter

研究概览

简要总结

Androgenetic alopecia is a type of progressive patterned hair loss. It ischaracterized by stepwise miniaturization of the hair follicle, resulting in alteration in the haircycle dynamics, leading to vellus transformation of the terminal hair. Nanofat transfer is a new and upcoming treatment option for androgenetic alopecia. Theadipose-derived stem cells have self-renewal capacity and also secrete various growth factorsthat have potential for hair growth

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient willing to give written informed consent (Annexure 1a, 1b, 1c)
  • Patients above 18 years of age and either sex
  • Patients with clinically and dermoscopically diagnosed as Androgenetic alopecia
  • Patients with BMI < 40kg/m2.

排除标准

  • Patient not willing to give written informed consent
  • Pregnant and lactating women
  • Patients with BMI < 18kg/m2
  • Patients currently suffering from an active autoimmune disease like SLE, Alopecia aerata
  • Patients suffering from any cardiovascular, renal, hematological, pulmonary, gastrointestinal or central nervous system disorders.
  • Patients with any bleeding or clotting disorders or on antiplatelet therapy.

结局指标

主要结局

Trichoscopic improvement in hair density and hair diameter

时间窗: Baseline, 1 month, 2 months and 6 months

次要结局

  • Improvement in Visual analogue scale(Improvement in global photography)

研究者

发起方
Varsha M
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验